Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Release: Recruitment Of Patients For The Phase II Study In Stress Urinary Incontinence With Cizolirtine Drug Has Been Completed

Esteve has recently obtained exciting results in preclinical animal models of urinary incontinence that provide additional support to the potential activity of cizolirtine in treating patients with Stress Urinary Incontinence. Cizolirtine has a unique and novel mechanism of action that confers it an enormous therapeutic potential.

Back to news